Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | (Q1)May 31, 2023 | (FY)Feb 28, 2023 | (Q4)Feb 28, 2023 | (Q3)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -0.03%3.59B | -0.84%3.41B | 4.87%13.86B | 3.65%3.35B | 4.08%3.47B | 4.97%3.59B | 6.80%3.44B | 7.67%13.21B | 9.30%3.23B | 10.54%3.33B |
Cost of revenue | -8.06%719M | -10.81%701M | 0.13%3.03B | -6.95%696M | 2.55%765M | 1.43%782M | 3.42%786M | 18.21%3.03B | 15.25%748M | 25.17%746M |
Gross profit | 2.13%2.87B | 2.11%2.71B | 6.27%10.83B | 6.80%2.66B | 4.56%2.71B | 6.03%2.81B | 7.80%2.66B | 4.89%10.19B | 7.62%2.49B | 6.86%2.59B |
Operating expense | 1.36%2.53B | -1.56%2.46B | -1.17%9.91B | -3.60%2.41B | -0.95%2.51B | -0.72%2.5B | 0.60%2.5B | 5.99%10.03B | 5.45%2.5B | 6.62%2.53B |
Staff costs | ---- | ---- | 0.73%1.51B | ---- | ---- | ---- | ---- | 6.47%1.5B | ---- | ---- |
Selling and administrative expenses | ---- | ---- | -2.47%3.31B | ---- | ---- | ---- | ---- | 12.57%3.4B | ---- | ---- |
-Selling and marketing expense | ---- | ---- | -4.40%803M | ---- | ---- | ---- | ---- | 9.95%840M | ---- | ---- |
-General and administrative expense | ---- | ---- | -1.84%2.51B | ---- | ---- | ---- | ---- | 13.45%2.56B | ---- | ---- |
Depreciation and amortization | ---- | ---- | -63.33%22M | ---- | ---- | ---- | ---- | -6.25%60M | ---- | ---- |
-Depreciation | ---- | ---- | -63.33%22M | ---- | ---- | ---- | ---- | -6.25%60M | ---- | ---- |
Rent and land expenses | ---- | ---- | -2.42%4.47B | ---- | ---- | ---- | ---- | -0.09%4.58B | ---- | ---- |
Other operating expenses | ---- | ---- | 21.34%597M | ---- | ---- | ---- | ---- | 27.13%492M | ---- | ---- |
Operating profit | 8.23%342M | 61.29%250M | 466.67%918M | 2,354.55%248M | 249.12%199M | 128.99%316M | 804.55%155M | -36.22%162M | 81.03%-11M | 18.75%57M |
Net non-operating interest income (expenses) | 0.00%1M | 0.00%1M | 0.00%4M | 0.00%1M | -50.00%1M | 0.00%1M | 1M | -20.00%4M | 0.00%1M | 100.00%2M |
Non-operating interest income | 0.00%1M | 0.00%1M | 0.00%4M | 0.00%1M | -50.00%1M | 0.00%1M | --1M | -20.00%4M | 0.00%1M | 100.00%2M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | -256.00%-89M | ||||||||
Less:Write off | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 256.00%89M | ---- | ---- |
Other non-operating income (expenses) | ||||||||||
Income before tax | 8.20%343M | 60.90%251M | 1,244.12%914M | 320.18%240M | 235.00%201M | 131.39%317M | 880.00%156M | -69.78%68M | -19.78%-109M | 25.00%60M |
Income tax | 1.53%133M | 12.70%71M | 204.88%375M | 700.00%104M | 120.00%77M | 84.51%131M | 1,475.00%63M | -17.45%123M | 425.00%13M | 34.62%35M |
Net income | 12.90%210M | 93.55%180M | 1,080.00%539M | 213.22%137M | 412.50%123M | 181.82%186M | 487.50%93M | -173.33%-55M | -37.50%-121M | 4.35%24M |
Net income continuous operations | 12.90%210M | 93.55%180M | 1,080.00%539M | 211.48%136M | 396.00%124M | 181.82%186M | 487.50%93M | -172.37%-55M | -40.23%-122M | 13.64%25M |
Noncontrolling interests | 15.60%126M | 84.48%107M | 197.22%321M | 822.22%83M | 115.15%71M | 84.75%109M | 728.57%58M | -32.50%108M | 1,000.00%9M | -15.38%33M |
Net income attributable to the company | 10.39%85M | 111.76%72M | 232.32%217M | 140.15%53M | 688.89%53M | 755.56%77M | 206.25%34M | -95.24%-164M | -53.49%-132M | 43.75%-9M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 10.39%85M | 111.76%72M | 232.32%217M | 140.15%53M | 688.89%53M | 755.56%77M | 206.25%34M | -95.24%-164M | -53.49%-132M | 43.75%-9M |
Gross dividend payment | ||||||||||
Basic earnings per share | 9.42%11.15 | 112.58%9.63 | 232.38%28.7 | 140.32%7 | 662.90%6.98 | 742.15%10.19 | 205.59%4.53 | -94.44%-21.68 | -51.09%-17.36 | 39.22%-1.24 |
Diluted earnings per share | 9.68%11.15 | 112.58%9.63 | 232.38%28.7 | 140.15%6.9973 | 662.90%6.98 | 755.56%10.1657 | 205.59%4.53 | -94.44%-21.68 | -51.67%-17.4268 | 41.30%-1.24 |
Dividend per share | 0.00%5 | 0 | 0.00%10 | 0.00%5 | 0 | 0.00%5 | 0 | 0.00%10 | 0.00%5 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |